Evidence map›Paper›PMID 35484214›Full record

ArticleBritish journal of cancer2022

HIF-1α stimulates the progression of oesophageal squamous cell carcinoma by activating the Wnt/β-catenin signalling pathway.

Kang Tang, Takeshi Toyozumi, Kentaro Murakami, Haruhito Sakata, Masayuki Kano, Satoshi Endo, Yasunori Matsumoto, Hiroshi Suito, Masahiko Takahashi, Nobufumi Sekino and 7 more

Open access · greenAbstract read
In one paragraph

Article in British journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Kang TangDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.ORCID http://orcid.org/0000-0002-5652-7376
Takeshi ToyozumiDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan. t_toyozumi@chiba-u.jp.ORCID http://orcid.org/0000-0002-0939-3299
Kentaro MurakamiDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Haruhito SakataDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Masayuki KanoDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Satoshi EndoDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Yasunori MatsumotoDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Hiroshi SuitoDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Masahiko TakahashiDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Nobufumi SekinoDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Ryota OtsukaDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Kazuya KinoshitaDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Soichiro HirasawaDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Jie HuDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Masaya UesatoDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Koichi HayanoDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Hisahiro MatsubaraDepartment of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.ORCID http://orcid.org/0000-0002-2335-4704
Chiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to clarify the significance of the crosstalk between hypoxia-inducible factor-1α (HIF-1α) and the Wnt/β-catenin pathway in oesophageal squamous cell carcinoma (ESCC).

methodsThe oncogenic role of HIF-1α in ESCC was investigated using in vitro and in vivo assays. The clinicopathological significance of HIF-1α, β-catenin and TCF4/TCF7L2 in ESCC were evaluated using quantitative real-time PCR and immunohistochemistry.

resultsThe expression level of HIF-1α, β-catenin, and TCF4/TCF7L2 in T.Tn and TE1 cell lines were elevated under hypoxia in vitro. HIF-1α knockdown suppressed proliferation, migration/invasion and epithelial-mesenchymal transition (EMT) progression, induced G0/G1 cell cycle arrest, promoted apoptosis and inhibited 5-fluorouracil chemoresistance in vitro. In vivo assays showed that HIF-1α is essential in maintaining tumour growth, angiogenesis, and 5-fluorouracil chemoresistance. Mechanically, we identified the complex between HIF-1α and β-catenin, HIF-1α can directly bind to the promoter region of TCF4/TCF7L2. The mRNA level of HIF-1α, β-catenin and TCF4/TCF7L2 were increased in ESCC tumour tissues compared to the corresponding non-tumour tissues. High levels of HIF-1α and TCF4/TCF7L2 expression were correlated with aggressive phenotypes and poor prognosis in ESCC patients.

conclusionsHIF-1α serves as an oncogenic transcriptional factor in ESCC, probably by directly targeting TCF4/TCF7L2 and activating the Wnt/β-catenin pathway.

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaHypoxia-Inducible Factor 1, alpha SubunitWnt Signaling Pathwaybeta CateninCell Line, TumorCell ProliferationDrug Resistance, NeoplasmFluorouracilHumansbeta CateninFluorouracilHIF1A protein, humanHypoxia-Inducible Factor 1, alpha Subunit

Identifiers

PMID35484214
PMCPMC9345968
OpenAlexW4224981517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.